Search research articles
Contact Us
Filters
Showing results (401-410 of 455) with videos related to
Page
of 46
Sort By:
JAMA Cardiology
|
November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension
Kevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
JACC. Heart Failure
|
October 19, 2024
Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease
Sophie L V M Stroeks, Michiel T H M Henkens, Fernando Dominguez, et al.
The New England Journal of Medicine
|
September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Pablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
JAMA Neurology
|
September 24, 2019
Medical Management vs Mechanical Thrombectomy for Mild Strokes: An International Multicenter Study and Systematic Review and Meta-analysis
Nitin Goyal, Georgios Tsivgoulis, Konark Malhotra, et al.
Journal for Immunotherapy of Cancer
|
September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
Shruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Journal of the American College of Cardiology
|
December 5, 2025
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial
Andrew Wang, Pablo Garcia-Pavia, Ahmad Masri, et al.
European Heart Journal
|
August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure
Douglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.
European Heart Journal
|
October 27, 2015
Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers
Godelieve R F Claes, Florence H J van Tienen, Patrick Lindsey, et al.
Journal of the American College of Cardiology
|
September 11, 2025
Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM
Sheila M Hegde, Xiaowen Wang, Pablo Garcia-Pavia, et al.
Journal of the American College of Cardiology
|
November 17, 2018
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
Fernando Domínguez, Sofía Cuenca, Zofia Bilińska, et al.
Page
of 46
Search research articles
Search
Showing results (401-410 of 455) with videos related to
Sort By:
Page
of 46
JAMA Cardiology
|
November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension
Kevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
JACC. Heart Failure
|
October 19, 2024
Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease
Sophie L V M Stroeks, Michiel T H M Henkens, Fernando Dominguez, et al.
The New England Journal of Medicine
|
September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Pablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
JAMA Neurology
|
September 24, 2019
Medical Management vs Mechanical Thrombectomy for Mild Strokes: An International Multicenter Study and Systematic Review and Meta-analysis
Nitin Goyal, Georgios Tsivgoulis, Konark Malhotra, et al.
Journal for Immunotherapy of Cancer
|
September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
Shruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Journal of the American College of Cardiology
|
December 5, 2025
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial
Andrew Wang, Pablo Garcia-Pavia, Ahmad Masri, et al.
European Heart Journal
|
August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure
Douglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.
European Heart Journal
|
October 27, 2015
Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers
Godelieve R F Claes, Florence H J van Tienen, Patrick Lindsey, et al.
Journal of the American College of Cardiology
|
September 11, 2025
Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM
Sheila M Hegde, Xiaowen Wang, Pablo Garcia-Pavia, et al.
Journal of the American College of Cardiology
|
November 17, 2018
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
Fernando Domínguez, Sofía Cuenca, Zofia Bilińska, et al.
Page
of 46